Drug Patent Expirations for the week of June 10, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| IMITREX | Glaxosmithkline | sumatriptan | 5,705,520*PED | Jun 10, 2012 | |||||
| LESCOL XL | Novartis | fluvastatin sodium | 5,356,896*PED | Jun 12, 2012 | |||||
| LESCOL | Novartis | fluvastatin sodium | 5,356,896*PED | Jun 12, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment